Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

Haemonetics (NYSE: HAE) will publish fourth quarter and fiscal year 2026 results at 6:00 am ET on May 7, 2026.

Rhea-AI Summary

Haemonetics (NYSE: HAE) will publish fourth quarter and fiscal year 2026 results at 6:00 am ET on May 7, 2026. A conference call with investors and analysts is scheduled for 8:00 am ET on May 7, 2026.

Participants can join via teleconference after registration to receive a dial-in number and personalized PIN. A live webcast will be available on Haemonetics' investor relations website and a replay will be accessible for one year starting May 7, 2026 at 11:00 am ET.

Argus Apr 2 session

+1.05% close to close Open Argus

Details

News Market Reaction – HAE

In the Apr 2 session, HAE gained 1.05%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for Haemonetics’ fourth quarter and fiscal year 2026 results, w...

Analysis

This announcement sets the timetable for Haemonetics’ fourth quarter and fiscal year 2026 results, with publication at 6:00 am ET on May 7, 2026 and an 8:00 am ET conference call plus a 1 year replay. It continues a consistent pattern of advance earnings-date notices. Investors may focus next on the underlying financial performance, commentary on recent acquisitions, and any updates on capital allocation or leverage discussed during the call.

Key Figures

Earnings release time: 6:00 am ET Conference call time: 8:00 am ET Earnings date: May 7, 2026 +1 more

Earnings release time

6:00 am ET

Fourth quarter and fiscal year 2026 results on May 7, 2026

Conference call time

8:00 am ET

Investor and analyst call on May 7, 2026

Earnings date

May 7, 2026

Scheduled publication of Q4 and FY26 results

Replay duration

1 year

Conference call and webcast replay availability starting May 7, 2026

Previous Earnings date Reports

1 past event · Latest: Jan 07

Same Type 1 event

1. Jan 07

   Earnings date set

   24h Move

   +1.3%

   Announced Q3 FY26 results release timing and related conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, April 1, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, May 7, 2026. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 7, 2026.

The call can be accessed via teleconference at: Q4 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/7d678otf 

A replay of the conference call and webcast will be available for one year beginning on May 7, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of

hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

	Investor Contacts:
	Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
	(781) 356-9763	(203) 733-4987
	olga.guyette@haemonetics.com	david.trenk@haemonetics.com
	Media Contact:
	Josh Gitelson, Sr. Director-Global Communications
	(781) 356-9776
	josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2026-results-may-7-2026-302731954.html

SOURCE Haemonetics Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Haemonetics (HAE) release Q4 and FY2026 earnings results?

Haemonetics will release fourth quarter and fiscal year 2026 results at 6:00 am ET on May 7, 2026. According to the company, the release will be followed by an 8:00 am ET investor and analyst conference call the same day to discuss results.

How can investors join the Haemonetics (HAE) earnings call on May 7, 2026?

Investors can join the conference call by registering for the Q4 2026 Haemonetics earnings conference call to get a dial-in and PIN. According to the company, registration provides a personalized PIN and dial-in details for teleconference access.

Will Haemonetics (HAE) provide a webcast of the May 7, 2026 earnings call?

Yes, Haemonetics will provide a live webcast of the May 7, 2026 conference call on its investor relations website. According to the company, the webcast link will be available on the investor site and accessible at the scheduled call time.

Is there a replay available for the Haemonetics (HAE) May 7, 2026 earnings call?

A replay of the conference call and webcast will be available for one year beginning May 7, 2026 at 11:00 am ET. According to the company, the replay uses the same conference call webcast link provided for the live event.

What time should participants join the Haemonetics (HAE) May 7, 2026 earnings call?

Participants are advised to join about 10 minutes before the 8:00 am ET start time on May 7, 2026. According to the company, early joining is recommended though not required to ensure timely access using provided dial-in credentials.